Statistics

	Views
Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?	7

Select a period of time:

	Views
Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?	5

	Views
United States	5

	Views
Ashburn	1

RUNA digital repository